July 10, 2002

Time Trends in Primary HIV-1 Drug Resistance Among Recently Infected Persons

Key Points

Key points are not available for this paper at this time.

Abstract

The frequency of primary resistance to NNRTIs is increasing, although resistance to all available classes of antiretroviral therapy remains rare. Genotypic resistance testing in recently infected persons predicts time to viral suppression during therapy.

Bookmark

Cite This Study

Robert M. Grant (Wed,) studied this question.

synapsesocial.com/papers/69d93c7bed2e131d3c684080 https://doi.org/https://doi.org/10.1001/jama.288.2.181

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Transmission of Zidovudine-Resistant Human Immunodeficiency Virus Type 1 Variants Following Deliberate Injection of Blood from a Patient with AIDS: Characteristics and Natural History of the Virus1995 · 66 citations
2A Randomized, Controlled Trial of Indinavir, Zidovudine, and Lamivudine in Adults with Advanced Human Immunodeficiency Virus Type 1 Infection and Prior Antiretroviral Therapy1999 · 102 citations
3Heterosexual Transmission of Human Immunodeficiency Virus Type 1 Variants Associated with Zidovudine Resistance1994 · 68 citations
4A Short-Term Clinical Evaluation of L-697,661, a Non-Nucleoside Inhibitor of HIV-1 Reverse Transcriptase1993 · 147 citations
5Human Immunodeficiency Virus Type 1 Protease Genotypes and In Vitro Protease Inhibitor Susceptibilities of Isolates from Individuals Who Were Switched to Other Protease Inhibitors after Long-Term Saquinavir Treatment1998 · 102 citations

Bookmark